Compulsory Bioequivalence Testing Requirement under Further Deliberation

As the industry constituents has essentially reached a general consensus on the enforcement of small-unit packaging requirement for pharmaceutical products in a periodic rollout scheme, the compulsory bioequivalence testing requirement for generic drugs is deemed as the major point at issue.

On February 23rd, the Regulatory Reform Committee (RRC) conducted a comprehensive review on the vario...